ENDRA LIFE SCIENCES INC

NDRANASDAQ

🏆 #3865 by market capEarnings Aug 13US Equity

$4.41▼ $0.03 (−0.68%)

🌙 After hours$4.41▲ 0.00%Regular close · extended-hours price shown

1h—

24h▼ 0.7%

7d—

14d—

30d—

1y—

🏦Market Cap

$6M

Small Cap

📈Revenue Growth (YoY)

+0.0%

Slowing

📊Gross Margin

0.0%

Thin

💵FCF Margin

0.0%

Thin

⚖️P/S Ratio

0.0x

Cheap

Otter Score

Weak

No chart data available for NDRA.

Trading Snapshot

Day Range: $4.38 – $4.47
52-Week Range: $2.96 – $9.85
Volume: $4.08B
Avg Volume: $3.88B
Shares Outstanding: 1.3M
Next Earnings: Sep 4, 2026

Fundamentals Snapshot

Annual Revenue: $2M
Last Q Revenue: $423,484
P/E Ratio: -0.5
P/S Ratio: 0.0x
EPS (TTM): $-6.09
Dividend Yield: 0.00%

Why Investors Own NDRA

✓High-growth profile — revenue up +17.8% YoY with expanding US Equity exposure.
✓Healthy economics — 30% gross margin and 6% free-cash-flow margin.
✓New products and segments could unlock additional revenue streams.

⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

Financial Trends

Revenue (TTM)

$2M▲ +16.1% YoY

Gross Margin (TTM)

29.6%▲ +3.9% YoY

Operating Income (TTM)

$426,018▲ +16.1% YoY

Free Cash Flow (TTM)

$96,745▲ +16.1% YoY

About ENDRA LIFE SCIENCES INC

ENDRA Life Sciences Inc. specializes in advancing the capabilities of clinical diagnostic ultrasound. The company's primary development is thermo-acoustic enhanced ultrasound technology, which operates by emitting sound waves that echo off internal body components such as tissues, organs, and blood. This innovation is utilized in managing nonalcoholic fatty liver disease, meticulously monitoring temperature during thermoablative surgical procedures, detailed vascular imaging, and assessing tissue perfusion. Furthermore, ENDRA offers other diagnostic imaging modalities, including computed tomography (CT), magnetic resonance imaging (MRI), and conventional ultrasound. These instruments empower physicians to visualize internal anatomy, aiding in treatment guidance and the identification of various medical conditions like bone fractures, cancerous growths, indicators of heart disease, or internal bleeding. The company also maintains a research collaboration agreement with General Electric Company. Established in 2007, ENDRA Life Sciences Inc. is headquartered in Ann Arbor, Michigan.

🦦